Gastroenterology
Volume 131, Issue 2 , Pages 366-378 , August 2006

Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn’s Disease

  • Iris Dotan

      Affiliations

    • IBD Service, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • Corresponding Author InformationAddress requests for reprints to: Iris Dotan, MD, IBD Service, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; fax: (972) 3 6974622
    • ,
  • Sigal Fishman

      Affiliations

    • IBD Service, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • ,
  • Yaara Dgani

      Affiliations

    • IBD Service, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • ,
  • Mikael Schwartz

      Affiliations

    • Glycominds Ltd, Lod, Israel
    • ,
  • Amir Karban

      Affiliations

    • Department of Gastroenterology, Rambam Medical Center, Haifa, Israel
    • ,
  • Aaron Lerner

      Affiliations

    • Pediatric Gastroenterology and Nutrition Unit, Carmel Medical Center, Haifa, Israel
    • ,
  • Oori Weishauss

      Affiliations

    • Glycominds Ltd, Lod, Israel
    • ,
  • Larissa Spector

      Affiliations

    • Glycominds Ltd, Lod, Israel
    • ,
  • Avi Shtevi

      Affiliations

    • Glycominds Ltd, Lod, Israel
    • ,
  • Rom T. Altstock

      Affiliations

    • Glycominds Ltd, Lod, Israel
    • ,
  • Nir Dotan

      Affiliations

    • Glycominds Ltd, Lod, Israel
    • ,
  • Zamir Halpern

      Affiliations

    • IBD Service, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Received 8 August 2006 ,Accepted 12 April 2006.

References 

  1. Hodgson HJF . Ulcerative colitis versus Crohn’s disease-one disease or two? . In:  Allan RN ,  Rhodes JM ,  Hanauer SB ,  Keighley MRB ,  Alexander-Williams J ,  Fazio VW editor. Inflammatory bowel diseases . 3rd ed.. New York: Churchill Livingstone; 1997;p. 343–347
  2. Joossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, et al. The value of serologic markers in indeterminate colitis (a prospective follow-up study) . Gastroenterology . 2002;122:1242–1247
  3. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, et al. Inflammatory bowel disease (re-evaluation of the diagnosis in a prospective population based study in south eastern Norway) . Gut . 1997;40:328–332
  4. Price AB . Overlap in the spectrum of nonspecific inflammatory bowel disease—“colitis indeterminate.” . J Clin Pathol . 1978;31:567–577
  5. Riegler G , Arimoli A , Esposito P , Iorio R , Carratu R . Clinical evolution in an outpatient series with indeterminate colitis . Dis Colon Rectum . 1997;40:437–439
  6. Targan S . Serology and laboratory markers of disease activity . In:  Sartor RB ,  Sandborn WJ editor. Kirsner’s inflammatory bowel disease . 6th ed.. New York: Saunders; 2004;p. 442–452
  7. Reumaux D , Sendid B , Poulain D , Duthilleul P , Dewit O , Colombel JF . Serological markers in inflammatory bowel diseases . Best Pract Res Clin Gastroenterol . 2003;17:19–35
  8. Saxon A , Shanahan F , Landers C , Ganz T , Targan S . A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease . J Allergy Clin Immunol . 1990;86:202–210
  9. McKenzie H , Main J , Pennington CR , Parratt D . Antibody to selected strains of Saccharomyces cerevisiae (baker’s and brewer’s yeast) and Candida albicans in Crohn’s disease . Gut . 1990;31:536–538
  10. Sendid B, Colombel JF, Jacquinot PM, Faille C, Fruit J, Cortot A, et al. Specific antibody response to oligomannosidic epitopes in Crohn’s disease . Clin Diagn Lab Immunol . 1996;3:219–226
  11. Vasiliauskas EA , Kam LY , Karp LC , Gaiennie J , Yang H , Targan SR . Marker antibody expression stratifies Crohn’s disease into immunologically homogeneous subgroups with distinct clinical characteristics . Gut . 2000;47:487–496
  12. Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn’s disease define a clinical subgroup . Gastroenterology . 1996;110:1810–1819
  13. Walker LJ, Aldhous MC, Drummond HE, Smith BR, Nimmo ER, Arnott ID, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn’s disease are associated with disease severity but not NOD2/CARD15 mutations . Clin Exp Immunol . 2004;135:490–496
  14. Cohavy O, Bruckner D, Gordon LK, Misra R, Wei B, Eggena ME, et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope . Infect Immun . 2000;68:1542–1548
  15. Sutton CL, Kim J, Yamane A, Dalwadi H, Wei B, Landers C, et al. Identification of a novel bacterial sequence associated with Crohn’s disease . Gastroenterology . 2000;119:23–31
  16. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, et al. Bacterial flagellin is a dominant antigen in Crohn disease . J Clin Invest . 2004;113:1296–1306
  17. Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, et al. Selected loss of tolerance evidenced by Crohn’s disease-associated immune responses to auto- and microbial antigens . Gastroenterology . 2002;123:689–699
  18. Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease . Gastroenterology . 2004;126:414–424
  19. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease (prevalence and diagnostic role) . Gut . 1998;42:788–791
  20. Ruemmele FM , Targan SR , Levy G , Dubinsky M , Braun J , Seidman EG . Diagnostic accuracy of serologic assays in pediatric inflammatory bowel disease . Gastroenterology . 1998;115:822–829
  21. Buonomano R , Tinguely C , Rieben R , Mohacsi PJ , Nydegger UE . Quantitation and characterization of anti-Galα1-3Gal antibodies in sera of 200 healthy persons . Xenotransplantation . 1999;6:173–180
  22. McMorrow IM , Comrack CA , Sachs DH , DerSimonian H . Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(α1,3)Galactose epitope . Transplantation . 1997;64:501–510
  23. Willison HJ , Yuki N . Peripheral neuropathies and anti-glycolipid antibodies . Brain . 2002;125:2591–2625
  24. Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn’s disease (report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998) . Inflamm Bowel Dis . 2000;6:8–15
  25. Schwarz M, Spector L, Gargir A, Shtevi A, Gortler M, Altstock RT, et al. A new kind of carbohydrate array, its use for profiling antiglycan antibodies, and the discovery of a novel human cellulose-binding antibody . Glycobiology . 2003;13:749–754
  26. Damoiseaux JG, Bouten B, Linders AM, Austen J, Roozendaal C, Russel MG, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease (high prevalence in patients with celiac disease) . J Clin Immunol . 2002;22:281–288
  27. Barta Z , Csipo I , Szabo GG , Szegedi G . Seroreactivity against Saccharomyces cerevisiae in patients with Crohn’s disease and celiac disease . World J Gastroenterol . 2003;9:2308–2312
  28. Forcione DG , Rosen MJ , Kisiel JB , Sands BE . Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn’s disease . Gut . 2004;53:1117–1122
  29. Smith BR , Arnott ID , Drummond HE , Nimmo ER , Satsangi J . Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn’s disease . Inflamm Bowel Dis . 2004;10:521–528
  30. Rutgeerts P , Vermeire S . Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease . Gastroenterology . 1998;115:1006–1009
  31. Sandborn WJ, Loftus EV, Colombel JF, Fleming KA, Seibold F, Homburger HA, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn’s disease . Inflamm Bowel Dis . 2001;7:192–201
  32. Sitaraman SV, Klapproth JM, Moore DA, Landers C, Targan S, Williams IR, et al. Elevated flagellin-specific immunoglobulins in Crohn’s disease . Am J Physiol Gastrointest Liver Physiol . 2005;288:G403–G406
  33. Stone BA , Clarke AE . In: Chemistry and biology of (1-3)-b-glucan . Melbourne: La Trobe University Press; 1992;p. 283–363
  34. Merzendorfer H , Zimoch L . Chitin metabolism in insects (structure, function and regulation of chitin synthases and chitinases) . J Exp Biol . 2003;206:4393–4412
  35. Pang Z, Otaka K, Maoka T, Hidaka K, Ishijima S, Oda M, et al. Structure of β-glucan oligomer from laminarin and its effect on human monocytes to inhibit the proliferation of U937 cells . Biosci Biotechnol Biochem . 2005;69:553–558
  36. Zaidman BZ , Yassin M , Mahajna J , Wasser SP . Medicinal mushroom modulators of molecular targets as cancer therapeutics . Appl Microbiol Biotechnol . 2005;67:453–468
  37. Palma AS, Feizi T, Zhang Y, Stoll MS, Lawson AM, Diaz-Rodriguez E, et al. Ligands for the β-glucan receptor, dectin-1, assigned using “designer” microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides . J Biol Chem . 2006;281:5771–5779
  38. van Eijk M, van Roomen CP, Renkema GH, Bussink AP, Andrews L, Blommaart EF, et al. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity . Int Immunol . 2005;17:1505–1512
  39. Sotgiu S, Arru G, Fois ML, Barone R, Sanna A, Pugliatti M, et al. Multiple sclerosis and chitotriosidase (a novel association) . Multiple Sclerosis . 2005;11:S132
  40. Mizoguchi E . Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells . Gastroenterology . 2006;130:398–411
  41. Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability (a study in IBD families) . Inflamm Bowel Dis . 2001;7:8–15
  42. Harrer M, Reinisch W, Dejaco C, Kratzer V, Gmeiner M, Miehsler W, et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn’s disease? . Eur J Gastroenterol Hepatol . 2003;15:1281–1285
  43. Lindberg E , Magnusson KE , Tysk C , Jarnerot G . Antibody (IgG, IgA, and IgM) to baker’s yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease . Gut . 1992;33:909–913
  44. Konrad A , Rutten C , Flogerzi B , Styner M , Goke B , Seibold F . Immune sensitization to yeast antigens in ASCA-positive patients with Crohn’s disease . Inflamm Bowel Dis . 2004;10:97–105
  45. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, et al. Anti-Saccharomyces cerevisiae and antibeutrophil cytoplasmic antibodies as predicators of inflammatory bowel disease . Gut . 2005;54:1232–1236
  46. Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, et al. Sero-reactivity to microbial components in Crohn’s disease is associated with disease severity and progression, but not NOD2/CARD15 genotype . Am J Gastroenterol . 2004;99:2376–2384
  47. Halfvarson J, Standaert-Vitse A, Jarnerot G, Sendid B, Jouault T, Bodin L, et al. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease . Gut . 2005;54:1237–1243
  48. Mow WS, Landers CJ, Steinhart AH, Feagan BG, Croitoru K, Seidman E, et al. High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn’s disease (a pilot study) . Dig Dis Sci . 2004;49:1280–1286

 Not supported by award or grant.

PII: S0016-5085(06)00842-0

doi: 10.1053/j.gastro.2006.04.030

Gastroenterology
Volume 131, Issue 2 , Pages 366-378 , August 2006

Article Tools

* Image Usage & Resolution